Rock Springs Capital Management’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,266,546
| Closed | -$3.64M | – | 105 |
|
2024
Q4 | $3.64M | Hold |
1,266,546
| – | – | 0.14% | 82 |
|
2024
Q3 | $3.26M | Hold |
1,266,546
| – | – | 0.11% | 91 |
|
2024
Q2 | $2.48M | Buy |
1,266,546
+354,609
| +39% | +$695K | 0.07% | 98 |
|
2024
Q1 | $2.43M | Buy |
911,937
+79,000
| +9% | +$210K | 0.06% | 105 |
|
2023
Q4 | $3.45M | Sell |
832,937
-241,580
| -22% | -$1M | 0.09% | 86 |
|
2023
Q3 | $1.48M | Hold |
1,074,517
| – | – | 0.04% | 103 |
|
2023
Q2 | $3.36M | Buy |
1,074,517
+608,998
| +131% | +$1.91M | 0.08% | 96 |
|
2023
Q1 | $1.58M | Buy |
465,519
+99,534
| +27% | +$338K | 0.04% | 106 |
|
2022
Q4 | $1.65M | Hold |
365,985
| – | – | 0.04% | 106 |
|
2022
Q3 | $3.22M | Buy |
365,985
+690
| +0.2% | +$6.07K | 0.08% | 103 |
|
2022
Q2 | $4.2M | Buy |
365,295
+5,750
| +2% | +$66.1K | 0.12% | 99 |
|
2022
Q1 | $6.29M | Buy |
359,545
+7,488
| +2% | +$131K | 0.16% | 97 |
|
2021
Q4 | $11.4M | Buy |
352,057
+1,230
| +0.4% | +$39.9K | 0.26% | 87 |
|
2021
Q3 | $14.1M | Buy |
+350,827
| New | +$14.1M | 0.3% | 88 |
|